Friday, January 30, 2026

This New Drug Could Stop Kidney Failure After Heart Surgery

Bilix receives MFDS approval for Phase 2a trial of Brixelle, targeting acute kidney injury in cardiac surgery patients.

Xi Jinping Urges “Patience” On North Korea… Shields Pyongyang Over Peninsula Issues

President Lee Jae Myung urges China to mediate North Korean issues, but China's emphasis on patience indicates limited willingness for action.

British Public Agencies Turn to AI, But Struggle with Data and Costs

The UK leads Europe in AI adoption within the public sector, with 75% using generative AI, despite concerns over data security and costs.

Dae Hyun Moon

Author's Latest

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Global Pharma Giants Join Samsung Biologics in Major Climate Pledge to Cut Supply-Chain Emissions by 2030

Samsung Biologics leads a global initiative to reduce carbon emissions in healthcare, aiming for sustainability and renewable energy by 2030.

Tylenol Stock Plunges: Trump’s Autism Warning Rattles $17B Market

Tylenol faces scrutiny over potential autism link during pregnancy, with mixed responses from the medical community and FDA caution.

CG MedTech’s Spine System Gets U.S. Debut in Texas Surgery

CG MedTech's INNOVERSE Spinal System gains FDA clearance and is successfully used in surgeries, marking a milestone for Korean medical devices.

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.